
### [NCIT:C7113](http://purl.obolibrary.org/obo/NCIT_C7113)
**Label:** Endometrioid Tumor

**Subclasses:** [NCIT:C113239](http://purl.obolibrary.org/obo/NCIT_C113239) (Uterine Carcinosarcoma, Heterologous Type), [NCIT:C113238](http://purl.obolibrary.org/obo/NCIT_C113238) (Uterine Carcinosarcoma, Homologous Type), [NCIT:C27850](http://purl.obolibrary.org/obo/NCIT_C27850) (Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells), [NCIT:C8975](http://purl.obolibrary.org/obo/NCIT_C8975) (Malignant Mixed Mesodermal (Mullerian) Tumor), [NCIT:C6279](http://purl.obolibrary.org/obo/NCIT_C6279) (Fallopian Tube Endometrioid Adenocarcinoma), [NCIT:C6257](http://purl.obolibrary.org/obo/NCIT_C6257) (Ovarian Endometrioid Tumor), [NCIT:C7983](http://purl.obolibrary.org/obo/NCIT_C7983) (Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor), [NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma), [NCIT:C42700](http://purl.obolibrary.org/obo/NCIT_C42700) (Uterine Carcinosarcoma), [NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma), [NCIT:C40069](http://purl.obolibrary.org/obo/NCIT_C40069) (Borderline Ovarian Endometrioid Adenofibroma), [NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma), [NCIT:C9192](http://purl.obolibrary.org/obo/NCIT_C9192) (Ovarian Carcinosarcoma), [NCIT:C27839](http://purl.obolibrary.org/obo/NCIT_C27839) (Endometrial Endometrioid Adenocarcinoma, Secretory Variant), [NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation), [NCIT:C3769](http://purl.obolibrary.org/obo/NCIT_C3769) (Endometrioid Adenocarcinoma), [NCIT:C7979](http://purl.obolibrary.org/obo/NCIT_C7979) (Ovarian Endometrioid Adenocarcinoma), [NCIT:C27289](http://purl.obolibrary.org/obo/NCIT_C27289) (Borderline Ovarian Endometrioid Cystadenofibroma), [NCIT:C27288](http://purl.obolibrary.org/obo/NCIT_C27288) (Ovarian Endometrioid Cystadenofibroma), [NCIT:C27287](http://purl.obolibrary.org/obo/NCIT_C27287) (Ovarian Endometrioid Adenofibroma), [NCIT:C8943](http://purl.obolibrary.org/obo/NCIT_C8943) (Metastatic Endometrioid Adenocarcinoma), [NCIT:C6343](http://purl.obolibrary.org/obo/NCIT_C6343) (Cervical Endometrioid Adenocarcinoma), [NCIT:C6287](http://purl.obolibrary.org/obo/NCIT_C6287) (Endometrial Endometrioid Adenocarcinoma), [NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma), [NCIT:C27846](http://purl.obolibrary.org/obo/NCIT_C27846) (Villoglandular Endometrial Endometrioid Adenocarcinoma), [NCIT:C27844](http://purl.obolibrary.org/obo/NCIT_C27844) (Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component), [NCIT:C27845](http://purl.obolibrary.org/obo/NCIT_C27845) (Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component), [NCIT:C40138](http://purl.obolibrary.org/obo/NCIT_C40138) (Uterine Ligament Endometrioid Adenocarcinoma), [NCIT:C27843](http://purl.obolibrary.org/obo/NCIT_C27843) (Endometrial Endometrioid Adenocarcinoma with Clear Cell Change), [NCIT:C36097](http://purl.obolibrary.org/obo/NCIT_C36097) (Cervical Carcinosarcoma), [NCIT:C6290](http://purl.obolibrary.org/obo/NCIT_C6290) (Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation), [NCIT:C40111](http://purl.obolibrary.org/obo/NCIT_C40111) (Fallopian Tube Endometrioid Tumor), [NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor), [NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma), [NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma), [NCIT:C9180](http://purl.obolibrary.org/obo/NCIT_C9180) (Uterine Corpus Carcinosarcoma), [NCIT:C40072](http://purl.obolibrary.org/obo/NCIT_C40072) (Benign Ovarian Endometrioid Tumor), [NCIT:C40051](http://purl.obolibrary.org/obo/NCIT_C40051) (Malignant Ovarian Endometrioid Tumor), 

**Class expressions from DL-Learner:**

- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 66.67%
- Thing 51.13%
- [UBERON:0000990](http://purl.obolibrary.org/obo/UBERON_0000990) (reproductive system) 45.53%
- [NCIT:C61542](http://purl.obolibrary.org/obo/NCIT_C61542) (Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present) 45.53%
- [NCIT:C53596](http://purl.obolibrary.org/obo/NCIT_C53596) (Epithelial Component Present) 39.03%
- [NCIT:C42075](http://purl.obolibrary.org/obo/NCIT_C42075) (Abnormal Tissue Present) 23.60%
- [NCIT:C36764](http://purl.obolibrary.org/obo/NCIT_C36764) (Abnormal Glandular Cell) 23.07%
- [NCIT:C36763](http://purl.obolibrary.org/obo/NCIT_C36763) (Neoplastic Glandular Cell) 23.07%
- [NCIT:C36753](http://purl.obolibrary.org/obo/NCIT_C36753) (Neoplastic Epithelial Cell) 21.12%
- [NCIT:C36745](http://purl.obolibrary.org/obo/NCIT_C36745) (Abnormal Epithelial Cell) 21.10%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 19.23%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 19.15%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 19.13%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 19.03%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 18.45%


